Zobrazeno 1 - 10
of 155
pro vyhledávání: '"O Closs"'
Autor:
L Sandvik, O. Closs, Beint S. Bentsen, K C L Carlsen, Groa B. Johannesdottir, M. Handeland, Ketil Størdal, H. K. Holm, Per Kristian Knudsen
Background: Epidemiological studies have shown an association between gastro-oesophageal reflux disease (GORD) and asthma, and oesophageal acid perfusion may cause bronchial constriction. However, no causative relation has been proven. Aim: To assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2414974c8dc95dfceab3e57d906d51e6
https://europepmc.org/articles/PMC1720585/
https://europepmc.org/articles/PMC1720585/
Autor:
E, Rosenqvist, E A, Høiby, G, Bjune, A, Aase, A, Halstensen, A K, Lehmann, J, Paulssen, J, Holst, T E, Michaelsen, H, Nøkleby, L O, Frøholm, O, Closs
Publikováno v:
Developments in biological standardization. 92
Three different formulations of an outer membrane vesicle (OMV) vaccine against group B meningococcal disease have been prepared and tested for immunogenicity and reactogenicity in adult volunteers. The vaccines were prepared with or without aluminiu
Publikováno v:
Neisseriae 1990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceac73855694623e26f9cc50ff74c99d
https://doi.org/10.1515/9783110867787-045
https://doi.org/10.1515/9783110867787-045
Publikováno v:
NIPH annals. 14(2)
An outer membrane vesicle vaccine against acute, systemic disease caused by meningococci of serogroup B has been developed. The vaccine has been tested consecutively in phase I and phase II clinical trials including more than 5000 volunteers. These t
Autor:
E, Rosenqvist, E A, Høiby, G, Bjune, K, Bryn, O, Closs, B, Feiring, A, Klem, H, Nøkleby, L O, Frølm
Publikováno v:
NIPH annals. 14(2)
Antibody responses after vaccination with three different formulations of a new meningococcal group B outer membrane vesicle (OMV) vaccine have been studied with the ELISA technique using four different antigens. Sera from about 1200 vaccinees partic
Publikováno v:
NIPH annals. 14(2)
A placebo controlled, double blind efficacy trial with a new outer membrane vesicle vaccine against systemic meningococcal disease of serogroup B, has been conducted in Norwegian secondary schools. The study was randomized at school level (1335 schoo
Autor:
J Eng, Ø Arnesen, J.H Fredriksen, L.K Solberg, Hanne Nøkleby, E Holten, L O Frøholm, Høiby Ea, E. Rosenqvist, Alfred Halstensen, L.S Bakketeig, O Closs, A-K Lindbak, Lystad A, B Hareide, Gunnar Bjune, Grønnesby Jk
Publikováno v:
Lancet (London, England). 338(8775)
For more than 15 years, Norway has had the highest incidence of meningococcal disease in northern Europe, with 80% of cases being due to serogroup B meningococci. The case-fatality has remained high, at about 10%. In this study, an outer membrane vac
Autor:
Groa B. Johannesdottir, Beint S. Bentsen, K St rdal, O. Closs, K C L Carlsen, M. Handeland, H. K. Holm
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition. 40:659
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition. 39:S436
Publikováno v:
Scandinavian Journal of Immunology. 7:487-493
Mononuclear cells (MC) were found in suspensions prepared from twenty-one out of twenty-two solid human neoplasms. In three cases it was calculated that more than 1% of the MC could represent contamination by blood MC. Due to technical difficulties a